Construction and immunogenicity of recombinant Mycobacterium bovis BCG expressing GP5 and M protein of porcine reproductive respiratory syndrome virus

Vaccine

Volumn 21, Issue 1-2, 2002, Pages 21-29

  Bastos, Reginaldo G ^a,b   Dellagostin, Odir A ^b   Barletta, Raúl G ^a   Doster, Allan R ^a   Nelson, Eric ^c   Osorio, Fernando A ^a  

^a UNIVERSITY OF NEBRASKA LINCOLN   (United States)

^b FEDERAL UNIVERSITY OF PELOTAS   (Brazil)

^c SOUTH DAKOTA STATE UNIVERSITY   (United States)

Author keywords

GP5 and M PRRSV protein; PRRSV; Recombinant BCG

Indexed keywords

BCG VACCINE; GAMMA INTERFERON; GLYCOPROTEIN GP 5; HEAT SHOCK PROTEIN 60; HYBRID PROTEIN; M PROTEIN; NEUTRALIZING ANTIBODY; RECOMBINANT VACCINE; UNCLASSIFIED DRUG; VIRUS PROTEIN; DNA VACCINE; GLYCOPROTEIN 5, PRRSV; MATRIX PROTEIN; PEPTIDE; RECOMBINANT PROTEIN; VIRUS ANTIBODY; VIRUS ENVELOPE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIGEN EXPRESSION; ARTERIVIRUS; ARTICLE; CELL SURFACE; CONTROLLED STUDY; CYTOPLASM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE CONTROL; IMMUNE RESPONSE; IMMUNOGENICITY; INOCULATION; MOUSE; MYCOBACTERIUM BOVIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; SPLEEN CELL; VIRUS INFECTION; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; CHEMISTRY; GENE EXPRESSION; GENE VECTOR; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; MOLECULAR CLONING; SWINE; SYNTHESIS; VACCINATION;

ANIMALS; ANTIBODIES, VIRAL; BLOTTING, WESTERN; CLONING, MOLECULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENETIC VECTORS; MICE; MICE, INBRED BALB C; MYCOBACTERIUM BOVIS; PEPTIDES; PORCINE RESPIRATORY AND REPRODUCTIVE SYNDROME VIRUS; RECOMBINANT PROTEINS; SWINE; VACCINATION; VACCINES, DNA; VIRAL ENVELOPE PROTEINS; VIRAL MATRIX PROTEINS;

EID: 0037159640     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(02)00443-7     Document Type: Article

References (53)

1. Bloom BR, Fine PEM. The BCG experience: Implications for future vaccines against tuberculosis. In: Bloom BR, editor. Tuberculosis: Pathogenesis, Protection, and Control. Washington, DC: ASM Press; 1994. p. 531-58.
2. Colditz G.A., Brewer T.F., Berkey C.S.et al. Efficacy of BCG vaccine in the prevention of tuberculosis: meta-analysis of the published literature. J. Am. Med. Assoc. 271:1994;678-702.
3. Stover C.K., de la Cruz V.F., Fuerst T.R.et al. New use of BCG for recombinant vaccines. Nature (London). 351:1991;456-460.
4. Dellagostin O.A., Wall S., Norman E., O'Shaugnessy T., Dale J.W., McFadden J. Construction and use of an integrative vectors to express foreign genes in mycobacteria. Mol. Microbiol. 10:1993;983-993.
5. Winter N., Lagranderie M., Rauzier J.et al. Expression of heterologous genes in Mycobacterium bovis BCG: induction of a cellular response against HIV-1 Nef protein. Gene. 109:1991;47-54.
6. Kremer L., Dupré L., Riveau G., Capron A., Locht C. Systemic and mucosal immune response after intranasal administration of recombinant Mycobacterium bovis bacillus Calmette-Guérin expressing glutathione S-transferase from Schistosoma haematobium. Infect. Immun. 66:1998;5669-5676.
7. Supply P., Sutton P., Coughlan S.N.et al. Immunogenicity of recombinant BCG producing the GRA1 antigen from Toxoplasma gondii. Vaccine. 17:1999;705-714.
8. Ohara N., Yamada T. Recombinant BCG vaccines. Vaccine. 19:2001;4089-4098.
9. Aldovini A., Young D.A. Humoral and cell-mediated immune response to live recombinant BCG-HIV vaccines. Nature (London). 351:1991;479-482.
10. Abomoelak B., Huygen K., Kremer L., Turneer M., Locht C. Humoral and cellular immune responses in mice immunized with recombinant Mycobacterium bovis Bacillus Calmette-Guérin producing a pertusis-tetanus toxin hybrid protein. Infect. Immun. 67:1999;5100-5105.
11. Leung N.J., Aldovini A., Young R.et al. The kinetics of specific immune responses in rhesus monkey inoculated with live recombinant BCG expressing SIV Gag, Pol, Env, and Nef proteins. Virology. 268:2000;94-103.
12. Jabbar I.A., Fernando G.J., Saunders N.et al. Immune responses induced by BCG recombinant for human papillomavirus L1 and E7 proteins. Vaccine. 18:2000;2444-2453.
13. Nascimento I.P., Dias W.O., Mazzantini R.P.et al. Recombinant Mycobacterium bovis BCG expressing pertussis toxin subunit S1 induces protection against intracerebral challenge with live Bordetella pertussis in mice. Infect. Immun. 68:2000;4877-4883.
14. Langermann S., Palaszynski S.R., Sadziene A., Stover C.K., Koenig S. Systemic and mucosal immunity induced by BCG vector expressing an outer-surface protein of Borrelia burgdorferi. Nature (London). 372:1994;552-555.
15. Connell ND, Medina-Acosta E, McMaster WR, Bloom BR, Russell DG. Effective immunization against cutaneous leishmaniasis with recombinant Bacille Calmette-Guérin expressing the Leishmania surface proteinase gp63. Proc Natl Acad Sci USA 1993;11473-7.
16. Langermann S., Palaszynski S.R., Burlein S.R.et al. Protective humoral response against pneumococcal infection in mice elicited by recombinant Bacille Calmette-Guérin vaccines expressing pneumococcal surface protein A. J. Exp. Med. 180:1994;2277-2286.
17. Matsumoto S., Yukitake H., Kanbara H., Yamada H., Kitamura A., Yamada T. Mycobacterium bovis Bacillus Calmette-Guérin induces protective immunity against infection by Plasmodium yoelii at blood-stage depending on shifting immunity toward Th1 type and inducing protective IgG2a after the parasite infection. Vaccine. 19:2000;779-787.
18. Wensoort G., Terpstra C., Pol J.M.A.et al. Mystery swine disease in The Netherlands: The isolation of Lelystad virus. Vet. Quarte. 13:1991;121-130.
19. Collins J.E., Benfield D.A., Christianson W.T.et al. Isolation of swine infertility and respiratory syndrome virus (isolate ATCC VR-2332) in North America and experimental reproduction of the disease in gnotobiotic pigs. J. Vet. Diagn. Invest. 4:1992;117-126.
20. Rossow K.D. Porcine reproductive and respiratory syndrome. Vet. Pathol. 35:1998;1-20.
21. Snijder E.J., Meulenberg J.J.M. The molecular biology of arteriviruses. J. Gen. Virol. 271:1998;4864-4871.
22. Conzelmann K.K.N., Visser N., van Woensel P., Tiel H.J. Molecular characterization of porcine reproductive and respiratory syndrome virus, a member of the arterivirus group. Virology. 193:1993;329-339.
23. Meulenberg J.J.M., Hulst M., De Meijer E.J., Moonen P.L.J.M. Subgenomic RNAs of Lelystad virus contain a conserved leader-body junction sequence. J. Gen. Virol. 74:1993;1697-1701.
24. Meulenberg J.J.M., Bestern A.P., De Kluyvier E.P.et al. Characterization of proteins encoded by ORFs 2 to 7 of Lelystad virus. Virology. 206:1995;155-163.
25. Murtaugh M.P., Elan M.R., Kakach L.T. Comparison of the structural proteins coding sequences of the VR-2332 and Lelystad virus strains of the PRRS virus. Arch. Virol. 140:1995;1451-1460.
26. Pirzadeh B., Dea S. Monoclonal antibodies to the ORF5 product of porcine reproductive and respiratory syndrome virus define linear neutralizing determinants. J. Gen. Virol. 78:1997;1867-1873.
27. Pirzadeh B., Dea S. Immune response in pigs vaccinated with plasmid DNA encoding ORF5 of porcine reproductive and respiratory syndrome virus. J. Gen. Virol. 79:1998;989-999.
28. Weiland E., Wieczorek-Krohmer M., Kohl D., Conzelmann K.K., Weiland F. Monoclonal antibodies to the GP5 of porcine reproductive and respiratory syndrome virus are more effective in virus neutralizing than monoclonal to the GP4. Vet. Microbiol. 66:1999;171-186.
29. Bautista E.M., Molitor T.W. T cell response to the structural polypeptides of porcine reproductive and respiratory syndrome virus. Arch. Virol. 144:1997;117-134.
30. Meulenberg J.J.M., Bende R.J., Pol J.M.A., Wensvoort G., Moormann R.J.M. Nucleocapsid protein N of Lelystad virus: expression by recombinant baculovirus, immunological properties, and suitability for detection of serum antibodies. Clin. Diagn. Lab. Immunol. 2:1995;652-656.
31. Kreutz L.C., Mengeling W.L. Baculovirus expression and immunological detection of the major structural proteins of porcine reproductive and respiratory syndrome virus. Vet. Microbiol. 59:1997;1-13.
32. Snapper S.B., Melton R.E., Mustafa S., Kieser T., Jacobs W.R. Jr. Isolation and characterization of efficient plasmid transformation mutants of Mycobacterium smegmatis. Mol. Microbiol. 4:1990;1911-1919.
33. Allende R., Lewis T.L., Lu Z.et al. North American and European porcine reproductive and respiratory syndrome viruses differ in non-structural protein coding regions. J. Gen. Virol. 80:1999;307-315.
34. Kim H.S., Kwang J., Yoon I.J., Joo H.S., Frey M.L. Enhanced replication of porcine reproductive and respiratory syndrome (PRRS) virus in a homogeneous subpopulation of MA-104 cell line. Arch. Virol. 133:1993;477-483.
35. Da Cruz F.W., McBride A.J.A., Conceição F.R., Dale J.W., McFadden J., Dellagostin O.A. Expression of the B cell and T cell epitopes of the rabies virus nucleoprotein in Mycobacterium bovis BCG and induction of an humoral response in mice. Vaccine. 20:2002;731-736.
36. Wilson I.A., Niman H.L., Houghten R.A., Cherenson A.R., Connlly M.L., Lerner R.A. The structure of an antigenic determinant in a protein. Cell. 37:1984;767-778.
37. Stover C.K., Bansal G.P., Hanson M.S.et al. Protective immunity elicited by recombinant Bacille Calmette-Guérin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate lyme disease vaccine. J. Exp. Med. 178:1993;197-209.
38. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. New York: Cold Spring Harbor Laboratory Press; 1989.
39. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Strubhul K. Current Protocol in Molecular Biology. New York: Wiley; 1998.
40. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London). 227:1970;680-685.
41. Wu H.-W., Fang Y., Farwell R.et al. A 10 kDa structural protein of porcine reproductive and respiratory syndrome virus encoded by ORF2b. Virology. 287:2001;183-191.
42. Hayward C.M., O'Gaora P., Young D.B.et al. Construction and murine immunogenicity of recombinant Bacille Calmette Guerin vaccines expressing the B subunit of E. coli heat labile enterotoxin. Vaccine. 17:1999;1272-1281.
43. Ashbridge K.R., Booth R.J., Watson J.D., Lathigra R.B. Nucleotide sequence of the 19 kDa antigen gene from Mycobacterium tuberculosis. Nucleic Acids Res. 17:1989;1249.
44. Himmelrich H., Lo-Man R., Winter N.et al. Immune response induced by recombinant BCG strains according to level of production of a foreign antigen: Ma1E. Vaccine. 18:2000;2636-2647.
45. Kremer L., Riveau G., Baulard A., Capron A., Locht C. Neutralizing antibody response elicited in mice immunized with recombinant Bacillus Calmette-Guérin producing the Schistosoma mansoni S-transferase. J. Immunol. 156:1996;4309-4317.
46. 197, a mutant diphtheria toxin. Infect. Immun. 69:2001;869-874.
47. Chujoh Y., Matsuo K., Yoshizaki H.et al. Cross-clade neutralizing antibody production against human immunodeficiency virus type 1 clade E and B strains by recombinant Mycobacterium bovis BCG-based candidate vaccine. Vaccine. 20:2002;797-804.
48. Yang L., Frey M.L., Yoon K.J., Zimmerman J.J., Platt K.B. Categorization of North American porcine reproductive and respiratory syndrome viruses: epitopes profile of the N, M, GP5 and GP3 proteins and susceptibility to neutralization. Arch. Virol. 145:2000;1599-1619.
49. Kagi D., Hengartner H. Different roles for cytoxic T cells in the control of infections with cytophatic versus non-cytophatic viruses. Curr. Opin. Immunol. 8:1996;472-477.
50. Lopez-Fuertes L., Domenech N., Alvarez B.et al. Analysis of cellular immune response in pigs recovered from porcine reproductive and respiratory syndrome virus infection. Virus. Res. 64:1999;33-42.
51. Rowland R.R., Robinson B., Stefanick J., Guanghua L., Lawson S.R., Benfield D.A. Inhibition of porcine reproductive and respiratory syndrome virus by interferon-gamma and recovery of virus replication with 2-aminopurine. Arch. Virol. 146:2000;539-555.
52. Hickey M.J., Arain T.M., Shawar R.M.et al. Luciferase in vivo expression technology: use of recombinant mycobacterial reporter strains to evaluate antimycobacterial activity in mice. Antimicrob. Agents Chemother. 40:1996;400-407.
53. Medeiros M.A., Dellagostin O.A., Armoa G.R.G.et al. Comparative evaluation of Mycobacterium vaccae as a surrogate cloning host for use in the study of mycobacterial genetics. Microbiology. 148:2002;1999-2009.